Alumis, Inc. (ALMS)
5.60
-0.53
(-8.65%)
USD |
NASDAQ |
Nov 13, 16:00
5.55
-0.05
(-0.89%)
After-Hours: 19:59
Alumis Net Income (Quarterly) : -94.88M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -94.88M |
| June 30, 2026 | -142.22M |
| March 31, 2026 | -93.05M |
| December 31, 2025 | -92.93M |
| September 30, 2025 | -110.75M |
| June 30, 2025 | 59.32M |
| March 31, 2025 | -98.96M |
| December 31, 2024 | -94.76M |
| Date | Value |
|---|---|
| September 30, 2024 | -93.12M |
| June 30, 2024 | -56.51M |
| March 31, 2024 | -49.85M |
| December 31, 2023 | -39.30M |
| September 30, 2023 | -43.38M |
| June 30, 2023 | -36.29M |
| March 31, 2023 | -36.03M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Johnson & Johnson | 210.00M |
| BioAge Labs, Inc. | -33.50M |
| ANI Pharmaceuticals, Inc. | 32.72M |
| Corcept Therapeutics, Inc. | 124.49M |
| Veru, Inc. | -6.988M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.907M |
| Total Expenses (Quarterly) | 96.79M |
| EPS Diluted (Quarterly) | -0.7338 |
| Enterprise Value | 330.18M |
| Gross Profit Margin (Quarterly) | 53.70% |
| Profit Margin (Quarterly) | -4.98K% |
| Earnings Yield | -62.13% |
| Normalized Earnings Yield | -56.62 |